PL406248A1 - Pharmaceutical composition, containing docosahexaenoic acid, and its application - Google Patents

Pharmaceutical composition, containing docosahexaenoic acid, and its application

Info

Publication number
PL406248A1
PL406248A1 PL406248A PL40624813A PL406248A1 PL 406248 A1 PL406248 A1 PL 406248A1 PL 406248 A PL406248 A PL 406248A PL 40624813 A PL40624813 A PL 40624813A PL 406248 A1 PL406248 A1 PL 406248A1
Authority
PL
Poland
Prior art keywords
docosahexaenoic acid
pharmaceutical composition
application
containing docosahexaenoic
risk
Prior art date
Application number
PL406248A
Other languages
Polish (pl)
Inventor
Jarosław Wypych
Aneta Pakieła-Rajtkowska
Original Assignee
Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequoia Spółka Z Ograniczoną Odpowiedzialnością filed Critical Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL406248A priority Critical patent/PL406248A1/en
Publication of PL406248A1 publication Critical patent/PL406248A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem wynalazku jest kwas dokozaheksaenowy, który można stosować w zmniejszaniu ryzyka przedwczesnego porodu. Kwas dokozaheksaenowy jest pochodzenia naturalnego, pozyskany został z alg naturalnych. Przedmiotem wynalazku jest również kompozycja farmaceutyczna w postaci kapsułki do stosowania w zmniejszaniu ryzyka przedwczesnego porodu. The present invention relates to docosahexaenoic acid which can be used to reduce the risk of premature delivery. Docosahexaenoic acid is of natural origin, obtained from natural algae. The invention also relates to a pharmaceutical composition in the form of a capsule for use in reducing the risk of premature delivery.

PL406248A 2013-11-26 2013-11-26 Pharmaceutical composition, containing docosahexaenoic acid, and its application PL406248A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL406248A PL406248A1 (en) 2013-11-26 2013-11-26 Pharmaceutical composition, containing docosahexaenoic acid, and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL406248A PL406248A1 (en) 2013-11-26 2013-11-26 Pharmaceutical composition, containing docosahexaenoic acid, and its application

Publications (1)

Publication Number Publication Date
PL406248A1 true PL406248A1 (en) 2015-06-08

Family

ID=53269075

Family Applications (1)

Application Number Title Priority Date Filing Date
PL406248A PL406248A1 (en) 2013-11-26 2013-11-26 Pharmaceutical composition, containing docosahexaenoic acid, and its application

Country Status (1)

Country Link
PL (1) PL406248A1 (en)

Similar Documents

Publication Publication Date Title
CL2017000969A1 (en) Compositions of factor viii and methods for making and using them (divisional application no. 2166-2014)
CL2016000882A1 (en) Compositions of arni against component c5 of the complement and methods for its use (divisional sol. No. 2710-15).
EA201890239A3 (en) FUMARATES AS A DEVELOPMENT AND THEIR APPLICATION IN THE TREATMENT OF DIFFERENT DISEASES
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
JO3773B1 (en) P2x7 modulators
EA201590518A1 (en) STABLE WATER COMPOSITIONS ADALIMUMAB
AR089931A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYLFUMARATE
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
UA116239C2 (en) Novel pyridine derivatives
IN2012DE00912A (en)
MX2015011767A (en) Compositions of crude algal oil.
MX340983B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
EA201592085A1 (en) APPLICATION OF FATTY ACID OF TALL OIL
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
MX2015016410A (en) Esters of oligo-hydroxycarboxylic acids and use thereof.
MY172557A (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015012318A (en) Solid state forms of a quinazoline derivative and its use as a braf inhibitor.
MX366651B (en) Crystal form alpha of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.
PH12016501117A1 (en) Pharmaceutical compositions of carotenoid
JO3688B1 (en) Pharmaceutical composition in the form of an oral suspension comprising a flavonoid fraction and xanthan gum
EA201591389A1 (en) COSMETIC COMPOSITIONS WITH TRICYCLOUDECANAMIDES
MX359887B (en) Chewable composition for oral administration and process for preparing thereof.